Teva CEO Vigodman resigns

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) said President and CEO Erez Vigodman resigned. Chairman Yitzhak Peterburg will hold both titles on an interim basis while the company searches for a permanent replacement.

The company said Vigodman and Teva's board were in "mutual agreement" that he would step down. He had been CEO since February 2014 (see BioCentury Extra, Jan. 9, 2014)...